Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    N-Phenylacetyl-L-Prolylglycine Ethyl Ester

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    $ API Ref.Price (USD/KG) : 655Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 157115-85-0, Gvs-111, Omberacetam, (s)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate, N-phenylacetyl-l-prolylglycine ethyl ester, Glycine, 1-(phenylacetyl)-l-prolyl-, ethyl ester
    Molecular Formula
    C17H22N2O4
    Molecular Weight
    318.4  g/mol
    InChI Key
    PJNSMUBMSNAEEN-AWEZNQCLSA-N
    FDA UNII
    4QBJ98683M
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate
    2.1.2 InChI
    InChI=1S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1
    2.1.3 InChI Key
    PJNSMUBMSNAEEN-AWEZNQCLSA-N
    2.1.4 Canonical SMILES
    CCOC(=O)CNC(=O)C1CCCN1C(=O)CC2=CC=CC=C2
    2.1.5 Isomeric SMILES
    CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CC2=CC=CC=C2
    2.2 Other Identifiers
    2.2.1 UNII
    4QBJ98683M
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Dvd-111

    2. Ethyl Phenylacetyl-pro-gly

    3. Gvs 111

    4. Gvs-111

    5. N-phenylacetyl-l-prolylglycine Ethyl Ester

    6. Omberacetam

    7. Sgs-111

    2.3.2 Depositor-Supplied Synonyms

    1. 157115-85-0

    2. Gvs-111

    3. Omberacetam

    4. (s)-ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate

    5. N-phenylacetyl-l-prolylglycine Ethyl Ester

    6. Glycine, 1-(phenylacetyl)-l-prolyl-, Ethyl Ester

    7. Ethyl 2-[[(2s)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate

    8. 4qbj98683m

    9. N-(1-(phenylacetyl)-l-prolyl)glycine Ethyl Ester

    10. Ethyl (2-phenylacetyl)-l-prolylglycinate

    11. Ethyl 1-(phenylacetyl)-l-prolylglycinate

    12. Gvs 111

    13. N-[1-(phenylacetyl)-l-prolyl]glycine Ethyl Ester

    14. Ethyl Phenylacetyl-pro-gly

    15. Unii-4qbj98683m

    16. Glycine, N-(1-(phenylacetyl)-l-prolyl)-, Ethyl Ester

    17. Omberacetam [inn]

    18. Noopept [who-dd]

    19. Schembl194807

    20. Glycine, 1-(2-phenylacetyl)-l-prolyl-, Ethyl Ester

    21. Noopept, >=98% (hplc)

    22. Chembl4303687

    23. Dtxsid80166214

    24. Dvd-111

    25. Sgs-111

    26. Zinc3812682

    27. Akos016012268

    28. Am84514

    29. Cs-1575

    30. Ncgc00378939-05

    31. As-10555

    32. Hy-17456

    33. J759.455k

    34. N1120

    35. Ethyl N-[1-(phenylacetyl)-l-prolyl]glycinate

    36. 1-(2-phenylacetyl)-l-prolylglycine Ethyl Ester

    37. C72975

    38. 115p850

    39. Q7049784

    2.4 Create Date
    2005-08-09
    3 Chemical and Physical Properties
    Molecular Weight 318.4 g/mol
    Molecular Formula C17H22N2O4
    XLogP31.5
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count7
    Exact Mass318.15795719 g/mol
    Monoisotopic Mass318.15795719 g/mol
    Topological Polar Surface Area75.7 Ų
    Heavy Atom Count23
    Formal Charge0
    Complexity432
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Neuroprotective Agents

    Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)